Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-22-014241
Filing Date
2022-05-18
Accepted
2022-05-17 19:06:46
Documents
13
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 153575
2 ex31-1.htm EX-31.1 3128
  Complete submission text file 0001493152-22-014241.txt   378924

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exdid-20211231.xsd EX-101.SCH 3045
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exdid-20211231_lab.xml EX-101.LAB 36509
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exdid-20211231_pre.xml EX-101.PRE 24005
7 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 6378
Mailing Address 5910 SOUTH UNIVERSITY BLVD C18-193 GREENWOOD VILLAGE CO 80121
Business Address 5910 SOUTH UNIVERSITY BLVD C18-193 GREENWOOD VILLAGE CO 80121 561-455-4822
PANACEA LIFE SCIENCES HOLDINGS, INC. (Filer) CIK: 0001552189 (see all company filings)

EIN.: 271085858 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38190 | Film No.: 22936475
SIC: 2833 Medicinal Chemicals & Botanical Products